Industry News
Biotechnology Industry News
AstraZeneca tacks on another $100M to wrap up over-budget R&D center
AstraZeneca tacks on another $100M to wrap up over-budget R&D center mbayer Mon, 03/07/2022 - 09:18
Death in Alpine’s Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy
Death in Alpine's Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy ntaylor Mon, 03/07/2022 - 09:08
SalubrisBio’s bispecific heart failure drug boosted by $32M cash injection
SalubrisBio's bispecific heart failure drug boosted by $32M cash injection ntaylor Mon, 03/07/2022 - 08:16
vTv CEO resigns 4 months into job after slashing workforce, refocusing pipeline
vTv CEO resigns 4 months into job after slashing workforce, refocusing pipeline klahucik Fri, 03/04/2022 - 08:50
Shionogi’s COVID-19 vaccine matches Pfizer’s Comirnaty in booster trial
Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial ntaylor Fri, 03/04/2022 - 08:40
BeiGene’s hematology CMO resigns in wake of solid tumor switch
BeiGene's hematology CMO resigns in wake of solid tumor switch ntaylor Fri, 03/04/2022 - 07:58
Synairgen’s NIH-sponsored COVID-19 trial paused a day after SAB study nixed completely
Synairgen's NIH-sponsored COVID-19 trial paused a day after SAB study nixed completely mbayer Thu, 03/03/2022 - 13:37
Bristol Myers Squibb to consolidate R&D units in San Diego in new complex
Bristol Myers Squibb to consolidate R&D units in San Diego in new complex esagonowsky Thu, 03/03/2022 - 11:27
Pardes poaches former Dermira CEO Thomas Wiggans amid rocky ride at stock market
Pardes poaches former Dermira CEO Thomas Wiggans amid rocky ride at stock market klahucik Thu, 03/03/2022 - 10:38
Pardes poaches former Dermira CEO Wiggans amid rocky ride at stock market
Pardes poaches former Dermira CEO Wiggans amid rocky ride at stock market klahucik Thu, 03/03/2022 - 10:38
Roche plans 4-year late-stage trial for Alzheimer’s candidate while awaiting crucial H2 readout
Roche plans 4-year late-stage trial for Alzheimer's candidate while awaiting crucial H2 readout klahucik Thu, 03/03/2022 - 09:14
Atlas lands $450M fund to build fresh batch of biotechs
Atlas lands $450M fund to build fresh batch of biotechs ntaylor Thu, 03/03/2022 - 08:46
AstraZeneca, Sanofi reveal mixed hand in high-stakes RSV game, with hospitalization miss tarnishing primary endpoint hit
AstraZeneca, Sanofi reveal mixed hand in high-stakes RSV game, with hospitalization miss tarnishing primary endpoint hit ntaylor Thu, 03/03/2022 - 08:01
As Russia stacked troops on Ukraine’s border, Karuna’s trial partners got ready
As Russia stacked troops on Ukraine's border, Karuna's trial partners got ready mbayer Thu, 03/03/2022 - 01:10
Chutes & Ladders—Merck chief patient officer to retire to become CEO of NIH nonprofit
Chutes & Ladders—Merck chief patient officer to retire to become CEO of NIH nonprofit klahucik Wed, 03/02/2022 - 15:40
Avalo adjusts almost entire pipeline weeks after CEO, CFO say sayonara
Avalo adjusts almost entire pipeline weeks after CEO, CFO say sayonara klahucik Wed, 03/02/2022 - 14:45
Foresite Labs’ new $173M fund to bankroll fewer startups but ‘big ideas’ fueled by data
Foresite Labs' new $173M fund to bankroll fewer startups but 'big ideas' fueled by data klahucik Wed, 03/02/2022 - 13:42
SAB’s shares drop 45% after NIH ditches COVID-19 trial due to waning hospitalizations
SAB's shares drop 45% after NIH ditches COVID-19 trial due to waning hospitalizations mbayer Wed, 03/02/2022 - 10:11
Pfizer revs up to leave GSK in the dust as maternal RSV vax granted FDA breakthrough tag
Pfizer revs up to leave GSK in the dust as maternal RSV vax granted FDA breakthrough tag aarmstrong Wed, 03/02/2022 - 09:15
FDA slaps hold on Finch’s C. diff med to get info on COVID-19 screening for donor-derived therapy
FDA slaps hold on Finch's C. diff med to get info on COVID-19 screening for donor-derived therapy klahucik Wed, 03/02/2022 - 09:00